Drug metabolism in end-stage liver disease. In vitro activities of some phase I and phase II enzymes.
The activities of a number of drug metabolising enzymes were measured in liver samples obtained from three groups of subjects: normal donors, patients with primary biliary cirrhosis (PBC), and patients with other types of liver disease. In the latter group, all the enzyme activities determined were impaired relative to the normal group. In the PBC group, however, enzyme activities were altered more selectively. (a) Activities of the methyl cholanthrene-inducible forms of cytochrome P-450 were decreased compared to normal controls, whereas the activities of the phenobarbitone-inducible isozymes were relatively unaffected. (b) Sulfotransferase activities were decreased significantly compared to the normal group, whereas sulfatase activities remained unaltered.
Iqbal
S
S
Liver Research Laboratories, Queen Elizabeth Hospital, Birmingham, United Kingdom.
Vickers
C
C
Elias
E
E
D000293:Adolescent; D000328:Adult; D000632:Aminopyrine / Q000378:metabolism; D002648:Child; D003374:Coumarins / Q000378:metabolism; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004970:Estrone / Q000378:metabolism; D005260:Female; D006801:Humans; D008095:Lithocholic Acid / Q000378:metabolism; D008107:Liver Diseases / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology; D008111:Liver Function Tests / Q000379:methods; D008297:Male; D008875:Middle Aged; D010078:Oxazines / Q000378:metabolism; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D015238:Sulfotransferases / Q000378:metabolism
D003374:Coumarins; D010078:Oxazines; D004364:Pharmaceutical Preparations; D000632:Aminopyrine; D004970:Estrone; C017299:7-ethoxycoumarin; C007649:ethoxyresorufin; D008095:Lithocholic Acid; D003577:Cytochrome P-450 Enzyme System; D015238:Sulfotransferases